Team:Stockholm/Modelling

From 2010.igem.org

(Difference between revisions)
Line 25: Line 25:
http://www.ncbi.nlm.nih.gov/pubmed/19597765
http://www.ncbi.nlm.nih.gov/pubmed/19597765
</s>
</s>
 +
 +
----
 +
 +
==PPI==
 +
 +
''The most obvious caveat with co-IP data is that a positive result does not imply a direct interaction between two proteins – binding could be mediated by other partners.''
 +
"Protein interactions: is seeing believing? J. P. Mackay et al. 2007"

Revision as of 14:01, 28 June 2010


Production Phase

Suggested Articles

http://www.ncbi.nlm.nih.gov/pubmed/17536514

http://www.ncbi.nlm.nih.gov/pubmed/17571257

http://www.ncbi.nlm.nih.gov/pubmed/19892171

http://www.ncbi.nlm.nih.gov/pubmed/20201800


Hassan: For production phase, there are several cases that we need to take care of. One of interesting subjects is "inclusion bodies". As Johan and Nina said, it is better to study about over expression.

Secretion

http://www.ncbi.nlm.nih.gov/pubmed/15763404

http://www.ncbi.nlm.nih.gov/pubmed/19597765


PPI

The most obvious caveat with co-IP data is that a positive result does not imply a direct interaction between two proteins – binding could be mediated by other partners. "Protein interactions: is seeing believing? J. P. Mackay et al. 2007"